
Join to view full profile
200 York Street Np15304Yale University School of MedicineNew Haven, CT 06520
Phone+1 203-200-5864
Fax+1 203-200-2713
Dr. Chiang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
Weill Cornell MedicineClass of 1999
Certifications & Licensure
FL State Medical License 2022 - Present
CT State Medical License 2008 - 2027
NY State Medical License 2000 - 2012
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- MK-3475 in Melanoma and NSCLC Patients With Brain Metastases
- Window Trial 5-aza in HNSCC, T-tare Start of enrollment: 2015 Feb 19
- A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer Start of enrollment: 2016 May 11
Publications & Presentations
PubMed
- Corrigendum to 'Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase...Silvia Novello, David R Spigel, Jian Fang, Yuanbin Chen, Yoshitaka Zenke
Journal of Thoracic Oncology. 2026-09-01 - Author Correction: SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.Lauren Averett Byers, Byoung Chul Cho, Alissa J Cooper, Anne C Chiang, Ji-Youn Han
Nature Medicine. 2026-08-01 - 5 citationsSEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.Lauren Averett Byers, Byoung Chul Cho, Alissa J Cooper, Anne C Chiang, Ji-Youn Han
Nature Medicine. 2026-08-01
Journal Articles
- Association of Broad-Based Genomic Sequencing with Survival Among Patients with Advanced Non–Small Cell Lung Cancer in the Community Oncology SettingRoy S Herbst, Amy P Abernethy, Janina A Longtine, Carolyn J Presley, Anne C Chiang, JAMA
- Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung CancerGuoping Cai, Sarah B Goldberg, Scott Gettinger, Anne Chiang, Roy S Herbst, David L Rimm, Kurt Schalper, Richard Lifton, Clinical Cancer Research
Press Mentions
Treatment of Small Cell Lung CancerMarch 31st, 2025
Enhancing Knowledge of Small Cell Lung Cancer Treatment and ManagementJanuary 18th, 2023
Standing up for Better Lung Cancer CareOctober 6th, 2022
Grant Support
- NCI National Clinical Trials Network (NCTN) - Network Lead Academic Participating SitesYALE UNIVERSITY2019–2032
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: